RONNALYN JACKSON: Open Payments
NPI 1326592247 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 34 payments from 15 companies in 2025. Trend: 2023 $1,611 · 2024 $1,042 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $195 |
| Corcept Therapeutics | 5 | $104 |
| SANOFI-AVENTIS U.S. LLC | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Lilly USA, LLC | 2 | $41 |
| ABBVIE INC. | 2 | $39 |
| Amgen Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| ABIOMED | 1 | $32 |
Products named: Ozempic, Korlym, TZIELD, FARXIGA, TRELEGY ELLIPTA, MOUNJARO, SYNTHROID, OTEZLA.
Industry payments across TX — which companies pay providers there.
